Pentobarbital will minimize the extent or effect of mestranol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Monitor. Monitor Closely (1)pentobarbital will minimize the extent or outcome of exemestane by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on. For patients getting exemestane that has a strong CYP3A4 inducer the https://josuemictj.pointblog.net/top-what-type-of-drug-is-nembutal-secrets-73164087